speb/financial-data huggingface dataset:
CPX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 380000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 26000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 26000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1004000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 1004000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 29000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 29000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 26000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 26000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 863000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 863000000.00
CPX.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 1403000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 209000000.00
CPX.TO income_statement (annual, 2024-12-31) — Normalized Income: 525894327.03
CPX.TO income_statement (quarterly, 2024-12-31) — Normalized Income: 5588850.17
CPX.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1144000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 438000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -594000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -253000000.00
CPX.TO income_statement (annual, 2024-12-31) — Operating Income: 810000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Operating Income: 46000000.00
CPX.TO income_statement (annual, 2024-12-31) — Operating Revenue: 3677000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Operating Revenue: 814000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 138979428.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 138979428.00
CPX.TO cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -5000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 157000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 157000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 178000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 178000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 108000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 108000000.00
CPX.TO income_statement (annual, 2024-12-31) — Other Gand A: 201000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Other Gand A: 51000000.00
CPX.TO income_statement (annual, 2024-12-31) — Other Income Expense: 298000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Other Income Expense: 290000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 709000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 709000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Inventories: 114000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Inventories: 114000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 293000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 78000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 145000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 145000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 182000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 182000000.00
CPX.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 221000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 70000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Properties: 9767000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 9767000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Other Receivables: 70000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 70000000.00
CPX.TO income_statement (annual, 2024-12-31) — Other Special Charges: 29000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Payables: 254000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Payables: 254000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 751000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 751000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Preferred Shares Number: 19000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Preferred Shares Number: 19000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Preferred Stock: 453000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 453000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -32000000.00
CPX.TO income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 34000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 8000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 453000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 453000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Preferred Stock Payments: -150000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Preferred Stock Payments: 0.00
CPX.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 36000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 36000000.00
CPX.TO income_statement (annual, 2024-12-31) — Pretax Income: 899000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Pretax Income: 287000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 26000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 12000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Purchase Of Business: -1224000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CPX.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1070000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -395000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Receivables: 568000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Receivables: 568000000.00
CPX.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1787000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 445000000.00
CPX.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 503000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 137000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -781000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -29000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -150000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CPX.TO balance_sheet (annual, 2024-12-31) — Restricted Cash: 14000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 14000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -74000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -74000000.00
CPX.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 254000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Salaries And Wages: 104000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Sale Of Business: 333000000.00
CPX.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 455000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Selling General And Administration: 155000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Share Issued: 138979428.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Share Issued: 138979428.00
CPX.TO income_statement (annual, 2024-12-31) — Special Income Charges: 251000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 298000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 4576000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 4576000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3379000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 3379000000.00
CPX.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 48894327.03
CPX.TO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 43588850.17
CPX.TO income_statement (annual, 2024-12-31) — Tax Provision: 198000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Tax Provision: 45000000.00
CPX.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
CPX.TO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.16
CPX.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 97000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 97000000.00
CPX.TO cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -38000000.00
CPX.TO cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -21000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Assets: 12930000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Assets: 12930000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 9395000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 9395000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Debt: 5110000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Debt: 5110000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4571000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 4571000000.00
CPX.TO income_statement (annual, 2024-12-31) — Total Expenses: 2966000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Total Expenses: 807000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 8359000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 8359000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 10982000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 10982000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7006000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7006000000.00
CPX.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 766000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 38000000.00
CPX.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: -5000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
CPX.TO income_statement (annual, 2024-12-31) — Total Unusual Items: 222000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: 278000000.00
CPX.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 222000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 278000000.00
CPX.TO balance_sheet (annual, 2024-12-31) — Working Capital: 595000000.00
CPX.TO balance_sheet (quarterly, 2024-12-31) — Working Capital: 595000000.00
CPX.TO income_statement (annual, 2024-12-31) — Write Off: 27000000.00
CPX.TO income_statement (quarterly, 2024-12-31) — Write Off: 0.00
CPX.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 268000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 988000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 694000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 617000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 139180095.00
CPX.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 1.03
CPX.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 865000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -288000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 133000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 4317000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 689000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 689000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -82000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -115000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -276000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 210000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 25000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -181000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 4317000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -75000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4640000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CPX.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 489000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1805000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 467000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 467000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1513000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 63000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 26000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 26000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 126000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 126000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 126000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 126000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 504000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 139515890.00
CPX.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.03
CPX.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 144000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 5000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — EBIT: 261000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — EBITDA: 387000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 24000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -24000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 5000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 689000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Financial Assets: 476000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -115000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 238000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -78000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -47000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -1000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 344000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 86000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 726000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 8205000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 499000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 292000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 63000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 63000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Interest Income: 2000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -9000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -85000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 207000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 9579000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -276000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1109000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 133000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4472000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4605000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -19000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1109000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 360000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Minimum Pension Liabilities: 1000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: -7000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Minority Interests: 1000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 4250000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -2000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Income: 151000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 144000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 150000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 151000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 151000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 150000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 150000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -58000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -19000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -19000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -58000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -5000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 12000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 8205000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -288000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3914000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 385000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 25000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 920000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 25000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 920000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 386000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 150242424.24
CPX.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 210000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -73000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Operating Income: 231000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 955000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 139289714.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 467000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 289000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 105000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 45000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 25000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 34000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 119000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 315000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 56000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 8205000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Payables: 694000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 694000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -7000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 7000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 198000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -288000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 617000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 489000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 126000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -19000000.00
CPX.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -21000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 41000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 86000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 139289714.00
CPX.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -1000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4640000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3914000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 242424.24
CPX.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 48000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CPX.TO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 2000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 12850000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9112000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 5072000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4633000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 757000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8217000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11045000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6704000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 236000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: -3000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1000000.00
CPX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1000000.00
CPX.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 292000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 335000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 441000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 626000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 575000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 151219128.00
CPX.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.92
CPX.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 689000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -141000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 155000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4983000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 308000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 308000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -79000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2611000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3103000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 143000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -79000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -349000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 4983000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -86000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4878000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 260000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1502000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 558000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 558000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1622000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Current Provisions: 69000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -74000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -74000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 138000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 138000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 138000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 138000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 548000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 151219128.00
CPX.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.92
CPX.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -139000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 33000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — EBIT: -117000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — EBITDA: 21000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 16000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -16000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -32000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 308000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Financial Assets: 385000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2611000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 65000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 236000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -6000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 21000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 156000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 142000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 650000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 11100000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 181000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 256000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 68000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 68000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Interest Income: 2000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 2000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -12000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -30000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 204000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 11819000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3103000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1051000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2105000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 155000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 6383000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6538000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 2105000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -23000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1051000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 418000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Minimum Pension Liabilities: 1000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Minority Interest: -7000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Minority Interests: -1000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -2973000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 669000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 6633000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -21000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Income: -132000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -139000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -131000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -132000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -132000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -131000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -131000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -62000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 2082000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 2082000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -62000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -49000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 11000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 11100000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -141000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4228000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 349000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 31000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 870000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 31000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 870000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 6000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -142621621.62
CPX.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 143000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 199000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Operating Income: -154000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 407000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 155110000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 558000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 369000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 90000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 89000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 31000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 86000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 103000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 304000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 55000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 11100000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Payables: 626000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 626000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 7000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -185000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -2973000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -141000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 734000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 260000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 138000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -23000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -261000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 53000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 142000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 155110000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -6000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4878000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4228000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 4378378.38
CPX.TO income_statement (quarterly, 2025-06-30) — Tax Provision: -54000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.29
CPX.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 159000000.00
CPX.TO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: 1000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 15171000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 11261000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 7096000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4871000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 595000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 10300000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 13669000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 8678000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -131000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -4000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 15000000.00
CPX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 15000000.00
CPX.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: -120000000.00
CPX.TO income_statement (annual, 2025-12-31) — +Operating Expense: 1246000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 325000000.00
CPX.TO income_statement (annual, 2025-12-31) — +Total Revenue: 3720000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1078000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 216000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 216000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 124000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 124000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2875000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2875000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 86000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 86000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CPX.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 181818182.00
CPX.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 155962899.00
CPX.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.88
CPX.TO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.12
CPX.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 865000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 204000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -864000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -288000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 154000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 154000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 5036000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5036000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 96000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 96000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 96000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 96000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -339000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -91000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2076000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -6000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3761000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -284000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 962000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 205000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -82000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 5000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Change In Payable: 96000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 96000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -26000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -7000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -30000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -722000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -84000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Common Stock: 4583000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 4583000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -311000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4404000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4404000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 667000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 21000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 758000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 758000000.00
CPX.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 2101000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 720000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 465000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 465000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Assets: 1542000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1542000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Debt: 347000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 347000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 347000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 347000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 80000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 80000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 1635000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1635000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 112000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 112000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -68000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -42000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -68000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -42000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Depreciation: 494000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 580000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 159000000.00
CPX.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 580000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 159000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 580000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 159000000.00
CPX.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 580000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 159000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 719000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 719000000.00
CPX.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 181818182.00
CPX.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 155962899.00
CPX.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.88
CPX.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.12
CPX.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 132000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -19000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 66000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 19000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 108000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 108000000.00
CPX.TO income_statement (annual, 2025-12-31) — EBIT: 469000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — EBIT: 52000000.00
CPX.TO income_statement (annual, 2025-12-31) — EBITDA: 1049000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — EBITDA: 211000000.00
CPX.TO income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 77000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 12000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -77000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -12000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -24000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1000000.00
CPX.TO cash_flow (annual, 2025-12-31) — End Cash Position: 119000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 119000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Financial Assets: 373000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Financial Assets: 373000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2077000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -5000000.00
CPX.TO balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 91000000.00
CPX.TO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 91000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 98000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -83000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 342000000.00
CPX.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 173000000.00
CPX.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
CPX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 0.00
CPX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -10000000.00
CPX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 2000000.00
CPX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 21000000.00